Entero Therapeutics, Inc. Annual Interest Expense in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Entero Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2015 to 2023.
  • Entero Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2024 was $66.2K, a 637% increase year-over-year.
  • Entero Therapeutics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $79.7K, a 314% increase year-over-year.
  • Entero Therapeutics, Inc. annual Interest Expense for 2023 was $22.5K, a 41.5% increase from 2022.
  • Entero Therapeutics, Inc. annual Interest Expense for 2022 was $15.9K, a 41.3% increase from 2021.
  • Entero Therapeutics, Inc. annual Interest Expense for 2021 was $11.2K, a 99.8% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $22.5K +$6.58K +41.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
2022 $15.9K +$4.64K +41.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 $11.2K -$5.83M -99.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-20
2020 $5.84M +$5.41M +1246% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $434K +$332K +326% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 $102K -$773K -88.4% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-30
2017 $875K -$5.06M -85.3% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
2016 $5.94M +$4.35M +274% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-16
2015 $1.59M Jan 1, 2015 Dec 31, 2015 10-K 2017-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.